Back
Return
Biography

Suresh Veeramani

Department of Internal Medicine

University of Iowa, USA


Email: suresh-veeramani@uiowa.edu


Qualifications


2003 Ph.D., Indian Veterinary Research Institute, India, Veterinary Immunology

2000 M.Sc., Indian Veterinary Research Institute, India, Veterinary Immunology

1998 B.Sc., Tamil Nadu Veterinary and Animal Sciences University, India, Veterinary Science


Publications (Selected)


1.   Veeramani S, Blackwell SE, Thiel WH, Yang ZZ, Ansell SM, Giangrande PH and Weiner GJ (2019) An RNA aptamer-based biomarker platform demonstrates high soluble CD25 occupancy by IL2 in the serum of follicular lymphoma patients. Cancer Immunol Res.7(9):1511-22. PMID: 31383650

2. Rogers LM, Veeramani S, and Weiner GJ (2014) Complement in monoclonal antibody therapy of cancer. Immunol Res. 59(1-3):203-10.

3. Zent CS, Taylor RP, Lindorfer MA, Beum PV, LaPlant B, Wu W, Call TG, Bowen DA, Conte MJ, Frederick LA, Link BK, Blackwell SE, Veeramani S, Baig NA, Viswanatha DS, Weiner GJ, Witzig TE. (2014) Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells. Am J Hematol. 89(7):757-65.

4. Muniyan S, Chou YW, Tsai TJ, Thomes P, Veeramani S, Benigno BB, Walker LD, McDonald JF, Khan SA, Lin FF, Lele SM, Lin MF. (2014) p66Shc longevity protein regulates the proliferation of human ovarian cancer cells. Mol Carcinog. doi: 10.1002/mc.22129. [Epub ahead of print]

5. Veeramani S, Chou YW, Lin FC, Muniyan S, Lin FF, Kumar S, Xie Y, Lele SM, Tu Y, Lin MF. (2012) Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radic Biol Med. 53(1):95-108.

6. Veeramani S, Wang SY, Dahle C, Blackwell S, Jacobus L, Knutson T, Button A, Link BK, Weiner GJ. (2011) Rituximab infusion induces NK activation in lymphoma patients with the high affinity CD16 polymorphism. Blood. 118(12):3347-9.

7. Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, Lin MF. (2010). Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. J Biol Chem. 285(31):23598-606

8. Wang SY, Veeramani S, Racila E, Cagley J, Fritzinger D, Vogel CW, St John W, Weiner GJ. (2009) Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model. Blood. 114(26):5322-30

9. Rajendran M, Thomes P, Zhang L, Veeramani S, Lin MF. (2010) p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis. Cancer Metastasis Rev. 29(1):207-222

10. Veeramani S, Lee MS and Lin MF (2009) Histidine-dependent acid phosphatases – Novel subfamily of protein tyrosine phosphatase Trends Biochem Sci 34(6):273-278

11. Alam SM, Rajendran M, Ouyang S, Veeramani S, Li, Z and Lin MF (2008) A Novel Role of Shc Adaptor Proteins in Steroid Hormone-Regulated Cancers. Endocr Relat Cancer. 16(1):1-16

12. Veeramani S, Yuan TC, Lin FF, Lin MF (2008) Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene 27(37):5057-5068

13. Yuan TC, Lin FF, Veeramani S, Chen SJ, Earp III HS, Lin MF (2007) ErbB-2 via PYK2 up-regulates the adhesive ability of androgen receptor-positive human prostate cancer cells Oncogene 26:7552-7559

14. Yuan TC, Veeramani S and Lin MF (2007) Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells Endocr Relat Cancer, 14:531-547

15. Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF (2006) Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells Endocr Relat Cancer 13: 151-167

16. Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS, Johansson SL and Lin MF (2005) Expression of p66Shc protein correlates with proliferation of human prostate cancer cells Oncogene 24: 7203-7212

17. Veeramani S, Yuan TC, Chen SJ, Lin FF, Petersen JE, Shaheduzzaman S, Srivastava S, MacDonald RG and Lin MF (2005) Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer Endocr Relat Cancer 12: 805-822